Status:
ACTIVE_NOT_RECRUITING
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Lead Sponsor:
The Cleveland Clinic
Conditions:
Cystic Fibrosis
Lung Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Detailed Description
The aim of this project is to implement a clinical tool utilizing predictors of mortality for patients with Cystic Fibrosis (CF) on the waiting list to identify candidates that should present for urge...
Eligibility Criteria
Inclusion
- Diagnosis of Cystic Fibrosis
- To be listed for lung transplant
- Has purchased home spirometer
Exclusion
- Diagnosis other than Cystic Fibrosis
- Unable to read
- Unable to use computer or smartphone device to access mobile application
Key Trial Info
Start Date :
April 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04687475
Start Date
April 20 2020
End Date
June 1 2026
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195